Newbridge Financial Services Group, Inc. Synaptogenix, Inc. Transaction History
Newbridge Financial Services Group, Inc.
- $224 Million
- Q1 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Synaptogenix, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 300 shares of SNPX stock, worth $1,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$1,205
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SNPX
# of Institutions
25Shares Held
955KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny401KShares$1.61 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$620,9730.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il83.5KShares$335,8460.0% of portfolio
-
Two Sigma Securities, LLC New York, NY83.4KShares$335,3040.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA68.5KShares$275,4580.0% of portfolio
About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $27.5M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...